Pharmaceutical major Ranbaxy Labortaories today said it remained confident that its products were safe and effective as the US Department of Justice (DoJ) withdrew a legal motion against it that charged fraudlent practice.
"Ranbaxy remains confident that its pharmaceutical products are safe and effective and remains committed to cooperatively working with all regulatory and legislative authorities," a company spokesperson said reacting to the news of the US DoJ withdrawing its motion filed at the District Court of Maryland.
The details can be read here.
No comments:
Post a Comment